Bharat Parenterals Ltd.

As of June 30, 2026, Bharat Parenterals Ltd. has 6.89M shares outstanding.

These figures are as of June 30, 2026.

These figures cover the twelve months ended June 30, 2026. The company generates approximately 8.11M in revenue per employee across its workforce of 398.50, a quick read on workforce productivity versus industry peers.

Over the twelve months ended June 30, 2026, Bharat Parenterals Ltd. recorded 45.34M in income tax expense. The company reported a pretax loss of -254.59M and -163.11M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

Over the twelve months ended June 30, 2026, Bharat Parenterals Ltd. generated 3.23B in revenue and converted that into -163.11M in net income, yielding earnings per share of -46.42. EBITDA reached 105.73M, while operating income came in at -237.60M.

Over the twelve months ended June 30, 2026, Bharat Parenterals Ltd. posted a gross margin of 49.47, reflecting its pricing power and cost economics. The operating margin of -7.35 and net profit margin of -5.05 provide insight into operational efficiency.